- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Westbrook Today
By the People, for the People
IDEXX Laboratories, Inc. $IDXX Shares Sold by Segall Bryant & Hamill LLC
Institutional investors decreased their holdings in the animal health and diagnostic company
Published on Mar. 5, 2026
Got story updates? Submit your updates here. ›
Segall Bryant & Hamill LLC, an investment management firm, decreased its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 32% in the third quarter of 2026. The firm now owns 14,343 shares of the company's stock, down from 21,086 shares previously.
Why it matters
IDEXX Laboratories is a leading provider of diagnostic products and services for the animal health, water testing, and food safety markets. Changes in institutional ownership can signal shifts in investor sentiment and market expectations for the company.
The details
According to a recent 13F filing, Segall Bryant & Hamill LLC sold 6,743 shares of IDEXX Laboratories during the third quarter, reducing its total position to 14,343 shares. The firm cited unspecified reasons for the decrease in its IDEXX holdings. Other major investors, including Bank of New York Mellon Corp and JPMorgan Chase & Co., have also modified their positions in IDEXX Laboratories in recent quarters.
- Segall Bryant & Hamill LLC decreased its IDEXX Laboratories holdings in the 3rd quarter of 2026.
The players
Segall Bryant & Hamill LLC
An investment management firm that decreased its position in IDEXX Laboratories, Inc.
Bank of New York Mellon Corp
A major institutional investor that has modified its IDEXX Laboratories holdings in recent quarters.
JPMorgan Chase & Co.
A major institutional investor that has modified its IDEXX Laboratories holdings in recent quarters.
The takeaway
The decrease in Segall Bryant & Hamill's IDEXX Laboratories holdings suggests a potential shift in investor sentiment around the company, though the specific reasons are unclear. Monitoring changes in institutional ownership can provide insights into market expectations for IDEXX Laboratories and the broader animal health and diagnostic industry.
